Loading clinical trials...

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT04867707

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

The objective is to determine if neuraminidase inhibition with zanamivir is efficacious as a therapeutic strategy to restore endothelial function in T2D patients.

Lead sponsor: University of Missouri-Columbia•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

RECRUITINGNA

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

RECRUITING

Collection of Human Metabolic Tissues

NCT02861781 · Obesity, Insulin Resistance, and more

RECRUITING

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more

RECRUITINGNA

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 25, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment14

Start dateJul 2021

Last updatedApr 25, 2025

Condition

Diabetes Mellitus, Type 2

Locations shown

University of Missouri, School of Medicine Clinical Research Center

Columbia, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 25, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions